IP Verse

Treatment Of Excessive Menstrual Bleeding Associated With Uterine Fibroids - EP2731613B1

PatentPatent Analysis

EP2731613

PREGLEM
Application Number
EP12755904A
Filing Date
Jul 12, 2012
Status
Revoked
Jul 10, 2020
Grant Date
Aug 30, 2017
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2731613B1 was granted to Preglem on Aug 30, 2017 following the initial filing on Jul 12, 2012 under the application number EP12755904A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ACCORD HEALTHCAREMay 30, 2018ADMISSIBLE
ZENTIVA KSMay 30, 2018ADMISSIBLE
GENERICS UKMay 29, 2018ADMISSIBLE
HELMMay 29, 2018ADMISSIBLE
HEXALMay 29, 2018ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents